T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CODX
2551
Co-Diagnostics
CODX
$5.49M
| $327K | ﹤0.01% |
1,320
-264
| -17% | -$67.9K |
|
2552
Commercial Vehicle Group
CVGI
$130M
| $327K | ﹤0.01% |
30,783
-12,617
| -29% | -$140K |
|
2553
Funko
FNKO
$335M
| $327K | ﹤0.01% |
15,348
-1,819
| -11% | -$41.4K |
|
2554
Phibro Animal Health
PAHC
$1.38B
| $327K | ﹤0.01% |
11,340
+327
| +3% | +$8.84K |
|
2555
Rhythm Pharmaceuticals
RYTM
$7.99B
| $327K | ﹤0.01% |
16,712
+1,247
| +8% | +$25.9K |
|
|
TELL
2556
DELISTED
Tellurian Inc.
TELL
| $327K | ﹤0.01% |
70,362
+35,780
| +103% | +$110K |
|
2557
Westwood Holdings Group
WHG
$184M
| $324K | ﹤0.01% |
14,900
-2,857
| -16% | -$54.3K |
|
|
ASXC
2558
DELISTED
Asensus Surgical, Inc.
ASXC
| $324K | ﹤0.01% |
102,241
-759
| -0.7% | -$1.9K |
|
2559
Barrett Business Services
BBSI
$800M
| $323K | ﹤0.01% |
17,800
+5,680
| +47% | +$104K |
|
2560
Ocugen
OCGN
$458M
| $323K | ﹤0.01% |
40,257
+27,957
| +227% | +$236K |
|
2561
Sportsman's Warehouse
SPWH
$46.8M
| $323K | ﹤0.01% |
18,199
-1,053,304
| -98% | -$18.6M |
|
|
PFC
2562
DELISTED
Premier Financial Corp. Common Stock
PFC
| $322K | ﹤0.01% |
11,336
+744
| +7% | +$23.1K |
|
|
OLP
2563
One Liberty Properties
OLP
$537M
| $321K | ﹤0.01% |
11,298
+1,233
| +12% | +$31.9K |
|
2564
NRC Health Common Stock
NRC
$471M
| $320K | ﹤0.01% |
6,965
+303
| +5% | +$14.4K |
|
2565
Carriage Services
CSV
$555M
| $318K | ﹤0.01% |
8,599
+316
| +4% | +$11.8K |
|
2566
Full Truck Alliance
YMM
$9.2B
| $318K | ﹤0.01% |
+15,623
| New | +$307K |
|
|
CSSE
2567
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $317K | ﹤0.01% |
+7,659
| New | +$269K |
|
2568
Veru
VERU
$46M
| $316K | ﹤0.01% |
3,914
+828
| +27% | +$72.9K |
|
2569
Altimmune
ALT
$560M
| $315K | ﹤0.01% |
31,985
-16,115
| -34% | -$220K |
|
2570
Hooker Furnishings Corp
HOFT
$158M
| $315K | ﹤0.01% |
9,097
+2,531
| +39% | +$94.3K |
|
2571
Hawthorn Bancshares
HWBK
$277M
| $315K | ﹤0.01% |
14,850
-4,751
| -24% | -$95.3K |
|
2572
Titan International
TWI
$438M
| $315K | ﹤0.01% |
37,191
-41,259
| -53% | -$402K |
|
2573
Anika Therapeutics
ANIK
$283M
| $312K | ﹤0.01% |
7,197
+708
| +11% | +$30.2K |
|
|
IVC
2574
DELISTED
Invacare Corporation
IVC
| $312K | ﹤0.01% |
38,657
+640
| +2% | +$5.33K |
|
2575
Banc of California
BANC
$3.11B
| $311K | ﹤0.01% |
17,714
+3,530
| +25% | +$63K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.